Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Marius Ilié, Paul Hofman 2017. PD-L1 22C3 LDT on VENTANA BenchMark ULTRA automate. protocols.io https://dx.doi.org/10.17504/protocols.io.ixacfieCopy Citation Copied
URL: https://dx.doi.org/DOI:10.17504/protocols.io.ixacfie
Authors: Marius Ilié, Paul Hofman
Summary: Optimised VENTANA BenchMark ULTRA protocol for PD-L1 assay using the concentrate 22C3 antibody.For the purpose of protocol development 95% of clinical specimens consisted of surgical resection specimens and the remaining 5% were bronchial biopsies and transbronchial mediastinal lymph node biopsies.
Associated Publications: Ilie M, Khambata-Ford S, Copie-Bergman C, Huang L, Juco J, Hofman V, Hofman P (2017) Use of the 22C3 anti–PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms. PLoS ONE 12(8): e0183023. doi: 10.1371/journal.pone.0183023
Affiliations: Université Côte d'Azur, University Hospital Federation OncoAge, Laboratory of Clinical and Experimental Pathology, Hôpital Pasteur, Nice, France, Université Côte d'Azur, University Hospital Federation OncoAge, Laboratory of Clinical and Experimental Pathology, Hôpital Pasteur, Nice, France
External URL: https://doi.org/10.1371/journal.pone.0183023
Version: 1
Publication Date: 2017
Expand AllComing soon.
Source: